{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":10,"sponsored":0,"items":[{"id":"n_77pf2hm4dimgd6ejdljq","seq":1715434,"kind":"article","title":"Aurobindo Pharma receives USFDA Final Approval for Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg","url":"https://www.equitybulls.com/category.php?id=376296","published":"2026-10-04T19:37:11Z","seen":"2026-10-04T19:37:11Z","lang":"en","source":{"id":"equitybulls.com","name":"equitybulls.com","domain":"equitybulls.com"},"via":"gdelt-gkg-english","topics":["economy","health","business"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_53w27dbu2i6w2ie5roua","category":"health","category_p":0.44,"sentiment":"neutral","tone":0.15,"political":0.07},{"id":"n_mhcctny733zkh6545mpa","seq":1694223,"kind":"article","title":"Aurobindo Pharma Gets USFDA Nod For Generic Epilepsy Tablets","url":"https://www.freepressjournal.in/india/aurobindo-pharma-gets-usfda-nod-for-generic-epilepsy-tablets","published":"2026-10-04T15:48:47Z","seen":"2026-10-04T16:16:08Z","lang":"en","country":"IN","source":{"id":"kite-prod-qt-images-s3-amazonaws-com-e3f293","name":"prod-qt-images.s3.amazonaws.com","domain":"prod-qt-images.s3.amazonaws.com"},"via":"kite-prod-qt-images-s3-amazonaws-com-e3f293","topics":["india","fpj shorts"],"authors":["PTI"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"mentions":3,"story":"st_mhcctny733zkh6545mpa","category":"health","category_p":0.65,"sentiment":"positive","tone":0.38,"political":0.04},{"id":"n_q4w6nxeqt4hxs7otyn7q","seq":1563389,"kind":"article","title":"Aurobindo Pharma: Strong dose of growth opportunities","url":"https://www.thehindubusinessline.com/portfolio/stock-fundamental-analysis-india/aurobindo-pharma-strong-dose-of-growth-opportunities/article71532020.ece","summary":"With key projects moving into commercial production, the drugmaker has stronger near-term growth visibility and also a long runway","published":"2026-10-03T16:06:31Z","seen":"2026-10-03T16:54:35Z","lang":"en","country":"IN","source":{"id":"kite-thehindubusinessline-com-b0e07f","name":"thehindubusinessline.com","domain":"thehindubusinessline.com","outlet":{"wikidata":"Q279739","name":"Business Line","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-thehindubusinessline-com-b0e07f","topics":["stock fundamentals"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"}],"image":"https://bl-i.thgim.com/public/incoming/jvfoe9/article71540294.ece/alternates/LANDSCAPE_1200/PO04_Aurobindo_Pharma_2.jpg","mentions":3,"story":"st_q4w6nxeqt4hxs7otyn7q","category":"economy-business","category_p":0.93,"sentiment":"positive","tone":0.72,"political":0.01},{"id":"n_53w27dbu2i6w2ie5roua","seq":1530914,"kind":"article","title":"Aurobindo Pharma Receives USFDA Final Approval For Perampanel Tablets, Market Size Estimated At ₹558 Crore","url":"https://www.freepressjournal.in/business/aurobindo-pharma-receives-usfda-final-approval-for-perampanel-tablets-market-size-estimated-at-558-crore","summary":"Mumbai: Aurobindo Pharma announced on October 3, 2026, that it has received final approval from the USFDA to manufacture and market Perampanel Tablets in 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg strengths. These tablets are bioequivalent and therapeutically equivalent to Fycompa® Tablets from Catalyst Pharmaceuticals, Inc. Market Opportunity The estimated market size for Perampanel Tablets stood at US$ 67 million (approximately ₹558 crore) for the twelve months ending August…","published":"2026-10-03T11:49:24Z","seen":"2026-10-03T12:29:27Z","lang":"en","country":"IN","source":{"id":"kite-freepressjournal-in-e26f41","name":"freepressjournal.in","domain":"freepressjournal.in","outlet":{"wikidata":"Q7735208","name":"The Free Press Journal","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-freepressjournal-in-e26f41","topics":["business","topnews","fpj shorts","google"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q868658","name":"perampanel","type":"other"}],"image":"https://media.assettype.com/freepressjournal/2026-02-27/lcxioz3d/aurobindo-pharma.jpg?w=280","mentions":3,"story":"st_53w27dbu2i6w2ie5roua","category":"economy-business","category_p":0.8,"sentiment":"positive","tone":0.49,"political":0.05},{"id":"n_xfstwimksd6ar2z52buq","seq":1475231,"kind":"article","title":"Aurobindo Pharma Acquires A1 Labs LLC For ₹127.32 Crore","url":"https://www.freepressjournal.in/business/aurobindo-pharma-acquires-a1-labs-llc-for-12732-crore","published":"2026-10-03T04:30:16Z","seen":"2026-10-03T04:38:49Z","lang":"en","country":"IN","source":{"id":"kite-prod-qt-images-s3-amazonaws-com-e3f293","name":"prod-qt-images.s3.amazonaws.com","domain":"prod-qt-images.s3.amazonaws.com"},"via":"kite-prod-qt-images-s3-amazonaws-com-e3f293","topics":["business","topnews","fpj shorts","google"],"authors":["FPJ Web Desk"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"}],"mentions":2,"story":"st_xfstwimksd6ar2z52buq","category":"economy-business","category_p":0.66,"sentiment":"positive","tone":0.39,"political":0.02},{"id":"n_kbsgaekynlbrgyipqrsa","seq":1402586,"kind":"article","title":"Aurobindo Pharma's Subsidiary Apitoria Completes Strategic Acquisition of A1 Biochem Group's Contract Research Services Business","url":"https://www.equitybulls.com/category.php?id=376265","published":"2026-10-02T17:54:26Z","seen":"2026-10-02T17:54:26Z","lang":"en","source":{"id":"equitybulls.com","name":"equitybulls.com","domain":"equitybulls.com"},"via":"gdelt-gkg-english","topics":["economy","business"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"}],"story":"st_kbsgaekynlbrgyipqrsa","category":"economy-business","category_p":0.73,"sentiment":"positive","tone":0.36,"political":0.08},{"id":"n_w62y2ryp7rxobaxnekyq","seq":1049862,"kind":"article","title":"Stocks to Watch Today: Aurobindo Pharma, Highway Infra, NCC, Blue Dart, Symbiotec Pharma, Shadowfax, Moneyview, Bata in focus on 01 October","url":"https://www.moneycontrol.com/news/business/markets/stocks-to-watch-today-aurobindo-pharma-highway-infra-ncc-blue-dart-symbiotec-pharma-shadowfax-moneyview-bata-in-focus-on-01-october-14042348.html","published":"2026-10-01T04:15:00Z","seen":"2026-10-01T04:15:26Z","lang":"en","source":{"id":"moneycontrol.com","name":"moneycontrol.com","domain":"moneycontrol.com","outlet":{"wikidata":"Q19573046","name":"Moneycontrol","type":"website","country":"IN","designations":["news website"]}},"via":"gdelt-gkg-english","topics":["economy","business"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"},{"id":"Q1970247","name":"Nature Climate Change","type":"org"},{"id":"Q4929036","name":"Blue Dart","type":"org"}],"story":"st_w62y2ryp7rxobaxnekyq","category":"economy-business","category_p":0.85,"sentiment":"neutral","tone":0.13,"political":0.03},{"id":"n_b73qcewhmxjzgwo63bia","seq":832020,"kind":"article","title":"Aurobindo Pharma Stock Declines 1.4% After Adverse Order In ₹4.60 Crore GST Demand Case In Telangana","url":"https://www.freepressjournal.in/business/aurobindo-pharma-stock-declines-14-after-adverse-order-in-460-crore-gst-demand-case-in-telangana","summary":"While the benchmark indices were trading in green on Wednesday, the stock of Aurobindo Pharma declined up to 1.4% after an adverse order in a Rs 4.6 crore GST demand case in Telangana. The company on Tuesday said the Telangana GST appellate authority has confirmed a demand seeking reversal of excess input tax credit (ITC) claimed by the company, involving a total amount of ₹4.60 crore. The order was issued by the Appellate Joint Commissioner (ST), Malkajgiri Division…","published":"2026-09-30T05:03:34Z","seen":"2026-09-30T05:40:25Z","lang":"en","country":"IN","source":{"id":"kite-freepressjournal-in-e26f41","name":"freepressjournal.in","domain":"freepressjournal.in","outlet":{"wikidata":"Q7735208","name":"The Free Press Journal","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-freepressjournal-in-e26f41","topics":["business","topnews","fpj shorts"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"},{"id":"Q677037","name":"Telangana","type":"place"}],"image":"https://media.assettype.com/freepressjournal/2026-02-27/lcxioz3d/aurobindo-pharma.jpg?w=280","story":"st_b73qcewhmxjzgwo63bia","category":"economy-business","category_p":0.93,"sentiment":"negative","tone":-0.6,"political":0.08},{"id":"n_yzuxpismqp3lbk3rpfiq","seq":824044,"kind":"article","title":"Aurobindo Pharma gets Rs 4.60-crore GST setback as appellate authority upholds ITC demand","url":"https://www.moneycontrol.com/news/business/aurobindo-pharma-gets-rs-4-60-crore-gst-setback-as-appellate-authority-upholds-itc-demand-14041631.html","published":"2026-09-30T04:52:20Z","seen":"2026-09-30T04:52:20Z","lang":"en","source":{"id":"moneycontrol.com","name":"moneycontrol.com","domain":"moneycontrol.com","outlet":{"wikidata":"Q19573046","name":"Moneycontrol","type":"website","country":"IN","designations":["news website"]}},"via":"gdelt-gkg-english","topics":["economy","business"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"}],"story":"st_glqk5iknqasajly4mumq","category":"economy-business","category_p":0.91,"sentiment":"negative","tone":-0.65,"political":0.29},{"id":"n_glqk5iknqasajly4mumq","seq":810426,"kind":"article","title":"GST appellate authority upholds ₹4.6 crore ITC claim order against Aurobindo Pharma","url":"https://www.thehindubusinessline.com/companies/gst-appellate-authority-upholds-46-crore-itc-claim-order-against-aurobindo-pharma/article71526562.ece","summary":"The order was passed by the Appellate Joint Commissioner (ST), Malkajgiri Division, Hyderabad, under the Central GST Act and Telangana GST Act for the 2020-21 financial year","published":"2026-09-30T03:04:57Z","seen":"2026-09-30T03:11:53Z","lang":"en","country":"IN","source":{"id":"kite-thehindubusinessline-com-db0d2b","name":"thehindubusinessline.com","domain":"thehindubusinessline.com","outlet":{"wikidata":"Q279739","name":"Business Line","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-thehindubusinessline-com-db0d2b","topics":["companies"],"entities":[{"id":"Q4822431","name":"Aurobindo Pharma","type":"org"}],"image":"https://bl-i.thgim.com/public/incoming/m14skf/article71526642.ece/alternates/LANDSCAPE_1200/Aurobindo-PharmGEDG10G13.4.jpg.jpg","mentions":3,"story":"st_glqk5iknqasajly4mumq","category":"economy-business","category_p":0.68,"sentiment":"neutral","tone":-0.14,"political":0.18}]}